Literature DB >> 25549600

Psychometric properties of the Mayo Elbow Performance Score.

Derya Celik1.   

Abstract

To translate and culturally adapt the Mayo Elbow Performance Score (MEPS), a widely used instrument for evaluating disability associated with elbow injuries, into Turkish (MEPS-T) and to determine psychometric properties of the translated version. The MEPS was translated into Turkish using published methodological guidelines. The measurement properties of the MEPS-T (construct validity and floor and ceiling effects) were tested in 91 patients with elbow pathology. The reproducibility of the MEPS-T was tested in 59 patients over 7-14 days. The responsiveness of the MEPS-T was tested in a subgroup of 46 patients diagnosed with lateral epicondylitis and who received conservative treatment for 6 weeks. The interclass correlation coefficient (ICC) was used to estimate the test-retest reliability. The construct validity was analyzed with the disabilities of the arm, shoulder and hand (DASH), Visual Analog Scale (VAS) and the Short Form 36 (SF-36). Effect size (ES) was used to assess the responsiveness. The distribution of floor and ceiling effects was determined. The MEPS-T showed very good test-retest reliability (ICC 0.89). The correlation coefficients between the MEPS-T and DASH and VAS were -0.61 and -0.53, respectively (p < 0.001). The highest correlations were between the MEPS-T and the mental component summary (r = 0.47, p = 0.001) and role emotional (r = 0.45, p = 0.001). The MEPS-T ES, 0.50, was moderate (95% CI 0.33-0.62). We observed no ceiling or floor effects. The MEPS-T represents a valid, reliable and moderately responsive instrument for evaluating patients with elbow disease.

Entities:  

Mesh:

Year:  2014        PMID: 25549600     DOI: 10.1007/s00296-014-3201-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

Review 1.  Guidelines for the process of cross-cultural adaptation of self-report measures.

Authors:  D E Beaton; C Bombardier; F Guillemin; M B Ferraz
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

2.  Current challenges in clinimetrics.

Authors:  Henrica C W de Vet; Caroline B Terwee; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-12       Impact factor: 6.437

3.  A comparison of two time intervals for test-retest reliability of health status instruments.

Authors:  Robert G Marx; Alia Menezes; Lois Horovitz; Edward C Jones; Russell F Warren
Journal:  J Clin Epidemiol       Date:  2003-08       Impact factor: 6.437

4.  Update: The Patient-rated Forearm Evaluation Questionnaire is now the Patient-rated Tennis Elbow Evaluation.

Authors:  Joy Macdermid
Journal:  J Hand Ther       Date:  2005 Oct-Dec       Impact factor: 1.950

5.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

6.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

7.  The development and validation of a patient-reported questionnaire to assess outcomes of elbow surgery.

Authors:  J Dawson; H Doll; I Boller; R Fitzpatrick; C Little; J Rees; C Jenkinson; A J Carr
Journal:  J Bone Joint Surg Br       Date:  2008-04

8.  Specificity and responsiveness of patient-reported and clinician-rated outcome measures in the context of elbow surgery, comparing patients with and without rheumatoid arthritis.

Authors:  J Dawson; H Doll; I Boller; R Fitzpatrick; C Little; J Rees; A Carr
Journal:  Orthop Traumatol Surg Res       Date:  2012-08-27       Impact factor: 2.256

9.  The reliability, validity and responsiveness of the Dutch version of the Oxford elbow score.

Authors:  Jeroen de Haan; Harold Goei; Niels W L Schep; Wim E Tuinebreijer; Peter Patka; Dennis den Hartog
Journal:  J Orthop Surg Res       Date:  2011-07-30       Impact factor: 2.359

10.  Is Platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: one year randomized clinical trial.

Authors:  Seyed Ahmad Raeissadat; Seyed Mansoor Rayegani; Hossein Hassanabadi; Rosa Rahimi; Leyla Sedighipour; Khalil Rostami
Journal:  BMC Sports Sci Med Rehabil       Date:  2014-03-18
View more
  5 in total

1.  Reliability, validity and critical appraisal of the cross-cultural adapted German version of the Mayo Elbow Performance Score (MEPS-G).

Authors:  A Papen; T Schöttker-Königer; A Schäfer; F Morrison; B Hollinger; K J Burkhart; R Nietschke; A Zimmerer; N Maffulli; F Migliorini; Marco M Schneider
Journal:  J Orthop Surg Res       Date:  2022-06-25       Impact factor: 2.677

2.  Nonoperative manipulative reduction with Chinese herbs for the treatment of a displaced olecranon fracture: A case report.

Authors:  Yu-Pei Chen; Yi-Shan Lan; Wen-Long Hu; Yu-Chiang Hung
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

3.  Extracapsular subcutaneous endoscopic treatment for refractory lateral epicondylalgia: technique, retrospective results, and prognostic factors.

Authors:  Yu-Ping Yang; Shuo Yuan; Guo-Qing Cui; Ning An; Ying-Fang Ao
Journal:  Ann Transl Med       Date:  2021-05

4.  Elbow hemiarthroplasty versus open reduction and internal fixation for AO/OTA type 13 C2 and C3 fractures of distal humerus in patients aged 50 years or above: a randomized controlled trial.

Authors:  Ali Al-Hamdani; Jeppe V Rasmussen; Kenneth Holtz; Bo S Olsen
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

Review 5.  Lateral Approach Versus Combined Lateral and Anteromedial Approach for Surgical Treatment of Terrible Triad of Elbow: A Meta-Analysis.

Authors:  Mukesh Kumar Meena; Karmbeer Singh; Sanjay Meena; Chetan Kumbhare; Dushyant Chouhan
Journal:  Bull Emerg Trauma       Date:  2020-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.